icon-    folder.gif   Conference Reports for NATAP  
 
  20th Conference on Retroviruses and
Opportunistic Infections
Atlanta, GA March 3 - 6, 2013
Back grey_arrow_rt.gif
 
 
 
Week 24 Primary Analysis of Cenicriviroc vs Efavirenz, in Combination with FTC/TDF, in Treatment-naïve HIV-1 Infected Adults with CCR5-tropic virus
 
 
  Reported by Jules Levin
CROI 2013 Atlanta March 3-6
 
(Study 652-2-202; NCT01338883)
 
Joseph Gathe1, Jerry Cade2, Edwin DeJesus3, Judith Feinberg4, Jay Lalezari5, Javier O. Morales Ramirez6, Anthony Scarsella7, Michael Saag8, Melanie Thompson9, Eric Lefebvre10
1Therapeutic Concepts, Houston, TX, US; 2Nevada AIDS Res Ed Society, Las Vegas, NV, US; 3Orlando Immunology Ctr, Orlando, FL, US; 4Univ Cincinnati, Cincinnati, OH, US; 5Quest Clin Res, San Francisco, CA, US; 6Clin Res P.R., Inc., San Juan, Puerto Rico; 7Pacific Oaks Med Grp, Beverly Hills, CA, US; 8Univ Alabama at Birmingham, Birmingham, AL, US; 9AIDS Res Consortium of Atlanta, Atlanta, GA, US; 10Tobira Therapeutics Inc., San Francisco, CA, US

CROI1.gif

CROI2.gif

CROI3.gif

CROI4.gif

CROI5.gif

CROI6.gif

CROI7.gif

CROI8.gif

CROI9.gif